Steven P. Fling - Concepedia

Author

Steven P. Fling

Also Known As

Fling, Steven P., Martin Cheever, S Fling, S P Fling, S. Fling, S.P. Fling, Steven Fling, Steven P Fling, Steven P. Fling

116

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington University of Minnesota Stanford University National Cancer Institute

About

Steven P. Fling is an author at Fred Hutch Cancer Center specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	5.2K
2	Natural Sciences	2	2	962
3	Biochemistry	2	2	962
4	Allergy	1	1	25
5	Biomolecular Engineering	1	1	28

Steven P. Fling

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target Laura M. Walker, Sanjay Phogat, Po-Ying Chan-Hui, Science ImmunologyNeutralizing EpitopeImmunotherapyVaccine TargetHuman Retrovirus	2009	1.7K
Broad neutralization coverage of HIV by multiple highly potent antibodies Laura M. Walker, Michael Huber, Katie J. Doores, Nature VaccinationHuman RetrovirusImmunologyAntiviral ResponseAntiviral Therapy	2011	1.5K
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma Paul Nghiem, Shailender Bhatia, Evan J. Lipson, New England Journal of Medicine	2016	1.2K
Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea Steven P. Fling, Dale S. Gregerson Analytical Biochemistry BiochemistryMedicineNatural SciencesBioanalysisMass Spectrometry	1986	934
Gene expression markers of Tumor Infiltrating Leukocytes Patrick Danaher, Sarah Warren, Lucas Dennis, Journal for ImmunoTherapy of Cancer	2017	824
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Journal of Clinical Oncology	2019	386
HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells Steven P. Fling, Donald Pious Nature HistocompatibilityImmunogenetics-Dmb GenesAutoimmune DiseaseHuman Leukocyte Antigen	1994	269
HLA-DMA and DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells Steven P. Fling, B Arp, Donald Pious Trends in Genetics HistocompatibilityDmb GenesImmunogeneticsAutoimmune DiseaseHuman Leukocyte Antigen	1994	251
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay, JAMA Oncology	2019	220
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu, Journal of Clinical Oncology	2019	217

Page 1